News
June 2007
Europe Backs Up Low-Dose Version of Cialis for Impotence
28 June 2007: Having received approval from European officials, now Cialis turns the first erectile dysfunction drug which can be utilized constantly....Read
More...
German Court Rebuffed Sanofi’s Challenge against Acomplia’s Non–Compensation
25 June 2007: Sanofi-Aventis’s legal challenge against the German government's decision to categorize Acomplia as a non-reimbursable medicine has been rejected by the Social Affairs Court in Berlin....Read
More...
Feeble Erections Conceals Many More
22 June 2007: It is one of the common problems which afflict nearly 30 per cent of men aged above 40 worldwide. It is none other than erectile dysfunction which becomes more common than it was ever before....Read
More...
Generic Pharmaceuticals Brush Aside FDA Panel’s Rejection
21 June 2007: Despite of the FDA’s advisory panel refusal to endorse acomplia for sale in the U.S, the
Indian pharmacies, which recently launched their own generic equivalents of the drug, seem resolute to not extract their generic versions from the market....Read
More...
“Brazilian Spider’s Venom May Result Better Erections When Coupled with Viagra”, Says Brazilian Scientists
19 June 2007: Brazilian Spider, often hailed as man’s Latin cousin, may play a credible role into Brazilian scientists’ escapade outlined for the development of a novel and effective cure for erectile dysfunction....Read
More...
Ulster Doctor Develops New Spray for Erectile Dysfunction
14 June 2007: The Ulster doctor, who contributed significantly to the development of Viagra, now come up with another revolutionary innovation hailed as “Spray and Stay” ...Read
More...
In-Flight Erections May Amplify after Viagra’s Use for Jetlag
11 June 2007: It seems that Virgin has to introduce major amendment in to its transatlantic flights’ seatback tray tables as the wonderful love drug Viagra has one more ...Read
More...
Sanofi- Dealing with Stiff Competition in India from Three Acomplia Equivalents
07 June 2007: It seems that Sanofi-Aventis’s acomplia still has to cross many barriers to make its way as three acomplia generics are giving tough competition...Read
More...
|